Infectious disease
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for April 27, 2020.
Merck will provide funding and work with the ISB investigators to develop targets for possible drugs and vaccines.
Although promising, it’s still unclear if this would actually prevent infection in people.
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for April 24, 2020.
Less than one month after Johnson & Johnson identified a lead vaccine candidate against COVID-19, the life sciences giant announced an agreement with Emergent BioSolutions to support the manufacturing needs for the potential medication.
Mesoblast announced that in a study of COVID-19 patients with moderate to severe acute respiratory distress syndrome, there was 83% survival with two intravenous infusions of the company’s experimental allogeneic mesenchymal stem cell candidate Ryoncil.
“Our goal is to get information out to the community and to share data as soon as is humanly possible, so that we can help accelerate ongoing efforts in the scientific and medical communities,” said Alex K. Shalek, the Pfizer-Laubach Career Development Associate Professor of Chemistry.
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for April 23, 2020.
Researchers at Switzerland-based Empa, ETH Zurich and Zurich University Hospital have developed a sensor that has the potential to identify SARS-CoV-2, the novel coronavirus that causes COVID-19, in the air.
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for April 22, 2020.
PRESS RELEASES